From Cardiovascular Prevention and Differential Diagnosis to the Treatment of Myocardial Damage-Experimental and Human Perspectives

Jan Pitha

doi:10.3390/ijms242316997

From Cardiovascular Prevention and Differential Diagnosis to the Treatment of Myocardial Damage-Experimental and Human Perspectives

Int J Mol Sci. 2023 Nov 30;24(23):16997. doi: 10.3390/ijms242316997.

Author

Jan Pitha¹

Affiliation

¹ Department of Cardiology, Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.

Abstract

Cardiovascular diseases are characterized by many clinical, morphological, functional, and biochemical markers, including age, sex, genetic factors, plasma lipids, glycemia, and many other laboratory parameters [...].

Publication types

Editorial

MeSH terms

Biomarkers
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / prevention & control
Diagnosis, Differential
Humans
Myocardium

Substances

Biomarkers

Grants and funding

No. LX22NPO5104/National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project No. LX22NPO5104) - Funded by the European Union - Next Generation EU